Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 DiabetesRalph A. DeFronzo, Steven C. Griffen, Linda Morrow et al.|Diabetes Care|2013Cited by 289
Interaction Between the Sodium‐Glucose–Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human SubjectsChristopher S. Wilcox, Steven C. Griffen, Wen Shen et al.|Journal of the American Heart Association|2018Cited by 137
of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 DiabetesRalph A. DeFronzo, Steven C. Griffen, Frank LaCreta et al.|Unknown|2013Cited by 0